RSV-SPECIFIC IMMUNE GLOBULIN CLINICAL TRIALS OVERVIEW 19

被引：0
|
作者：
Leonard E Weisman
机构：
[1] Professor of Pediatrics,
[2] Head,undefined
[3] Section of Neonatology,undefined
[4] Director,undefined
[5] Neonatal-Perinatal Medicine Fellowship Program,undefined
[6] Baylor College of Medicine,undefined
[7] and Chief,undefined
[8] Neonatology Service,undefined
[9] Texas Children's Hospital,undefined
来源：
Pediatric Research | 1997年 / 41卷 / 5期
关键词：
D O I：
10.1203/00006450-199705000-00038
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：736 / 736
相关论文
共 50 条
  • [21] Hospitalisation for RSV infection in ex-preterm infants - Implications for use of RSV immune globulin
    Thomas, M
    Bedford-Russell, A
    Sharland, M
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (02) : 122 - 127
  • [22] Isolation of RSV-specific, neutralizing human antibodies via blocked fanning of Fab combinatorial phage libraries
    Tsui, P
    Tornetta, MA
    Ames, RS
    Bankosky, BC
    Griego, S
    Silverman, C
    Porter, T
    Moore, G
    Sweet, RW
    [J]. VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1996, : 149 - 153
  • [23] RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN PRETERM INFANTS AND THE PROTECTIVE EFFECTS OF RSV IMMUNE GLOBULIN (RSVIG)
    GROOTHUIS, JR
    SIMOES, EAF
    HEMMING, VG
    LEVIN, MJ
    SONDHEIMER, H
    LEHR, MV
    LOUCH, GK
    HALL, CB
    POWELL, KR
    LONG, CE
    PINCUS, PR
    SCHNABEL, KC
    RODRIGUEZ, WJ
    ARROBIO, J
    KIM, HW
    PARROTT, RH
    FINK, R
    RUCKMAN, R
    REVENIS, M
    CHANEY, H
    PIAZZA, F
    MEISSNER, HC
    FULTON, DR
    MARX, GR
    GEGGEL, RL
    WELLIVER, RC
    TRISTRAM, DA
    SIBER, GR
    LESZCZYNSKI, J
    MCIVER, J
    HENSEN, SA
    VINCENT, MM
    [J]. PEDIATRICS, 1995, 95 (04) : 463 - 467
  • [24] RSV immune globulin prophylaxis: Is an ounce of prevention worth a pound of cure?
    Moler, FW
    [J]. PEDIATRICS, 1999, 104 (03) : 559 - 560
  • [25] USE OF INTRAVENOUS IMMUNE GLOBULIN THERAPY - AN OVERVIEW
    WORDELL, CJ
    [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (7-8): : 805 - 817
  • [26] A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate
    Chen, M.
    Chang, J. S.
    Nason, M.
    Rangel, D.
    Gall, J. G.
    Graham, B. S.
    Ledgerwood, J. E.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 362 (1-2) : 180 - 184
  • [27] Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis
    Dakhama, A
    Vitalis, TZ
    Hegele, RG
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (01) : 20 - 26
  • [28] A TRIAL OF RSV IMMUNE GLOBULIN IN INFANTS AND YOUNG-CHILDREN - THE FDAS VIEW
    ELLENBERG, SS
    EPSTEIN, JS
    FRATANTONI, JC
    SCOTT, D
    ZOON, KC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (03): : 203 - 204
  • [29] Clinical trials of COVID-19 vaccine development: a global overview
    Lopes, Joao Victor Antunes
    de Campos, Andre Luiz Sica
    de Moraes, Rafael Rodrigues
    Alves, Luciana Correia
    [J]. CADERNOS DE SAUDE PUBLICA, 2023, 39 (05):
  • [30] Combination therapies for COVID-19: An overview of the clinical trials landscape
    Akinbolade, Sola
    Coughlan, Diarmuid
    Fairbairn, Ross
    McConkey, Glenn
    Powell, Helen
    Ogunbayo, Dapo
    Craig, Dawn
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (04) : 1590 - 1597
12345